基本信息
views: 29
Career Trajectory
Bio
主要从事重大传染性疾病的致病机理、疫苗研制和生物治疗,以及肿瘤的分子细胞生物学致病机理的研究.
在丙型肝炎(HCV)和乳突瘤病毒(HPV)的研究方面取得了一些成果,主要是对HCV的非结构蛋白NS4B的研究; 和对因高危型HPV引起的宫颈癌的生物治疗的研究。
在丙型肝炎(HCV)和乳突瘤病毒(HPV)的研究方面取得了一些成果,主要是对HCV的非结构蛋白NS4B的研究; 和对因高危型HPV引起的宫颈癌的生物治疗的研究。
Research Interests
Papers共 192 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
International immunopharmacologyno. Pt 2 (2024): 113402-113402
Li Yang, Yiwen Gao,Qingyun Liu,Wenjing Li,Zimu Li, Dan Zhang, Rixin Xie,Yi Zheng,Hongzhong Chen,Xiaowei Zeng
SMALLno. 12 (2024)
MEDICINEno. 35 (2024)
Jifang Gong,Chang Liu,Jun Yao,Junli Xue,Jing Dai,Yinghua Ji,Ben Markman,Alison Hiong, Xiuli Yang,Rusen Zhao,Yi Zheng, Qingshan Li,Jun Wu,Minal A. Barve, Mihitha Hashara Ariyapperuma,Gary Edward Richardson, Xia Qin,Crystal Ying Qin,Lin Shen
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)
Zhaoxin Yang,Zhirang Zhang, Liyan Li,Zhangyan Jing,Yumeng Ma, Tianyu Lan,Yuan Li,Zhongda Lin,Wenli Fang,Jinxie Zhang, Jinling Zhang,Xin Liang,Benqing Wu,Yi Zheng,Xudong Zhang
Diabetes (2024)
biorxiv(2024)
Chunmei Bai,Junli Xue,Yi Zheng,Meili Sun,Jieer Ying,Fuxiang Zhou,Yiyi Yu,Yuping Sun,Ligang Xing,Yanqiao Zhang,Jinhua Wen,Jianping Xiong,Heshui Wu,Xiuli Yang, Lixin Wan,Shiwei Guo,Rusen Zhao, Zhizhen Zhu, Zhihua Gong,Jin Li
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)
Xiaoxuan Tu, Longxian Chen,Yi Zheng,Chenglin Mu,Zhiwei Zhang,Feiyu Wang, Yiqing Ren, Yingxin Duan,Hangyu Zhang,Zhou Tong,Lulu Liu, Xunqi Sun,Peng Zhao,Lie Wang,Xinhua Feng,Weijia Fang,Xia Liu
CHINESE CHEMICAL LETTERSno. 1 (2024)
Load More
Author Statistics
#Papers: 189
#Citation: 5385
H-Index: 32
G-Index: 69
Sociability: 7
Diversity: 0
Activity: 3
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn